HAIC Combined with Tislelizumab and Apatinib

DRUG2 trials

Sponsors

Yunfei Yuan, Binkui Li

Conditions

Intrahepatic Cholangiocarcinoma

Phase 2

HAIC Combined With Tislelizumab and Apatinib for Unresectable Intrahepatic Cholangiocarcinoma

Yunfei YuanIntrahepatic Cholangiocarcinoma

Start: 2022-07-21End: 2023-09-01Target: 17Updated: 2022-08-05

HAIC Combined With Sintilimab and Bevacizumab for Unresectable Intrahepatic Cholangiocarcinoma

Binkui LiIntrahepatic Cholangiocarcinoma

Start: 2023-05-31End: 2023-12-31Target: 17Updated: 2023-04-13